These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
416 related items for PubMed ID: 21798969
1. Mortality and associated risk factors in consecutive patients admitted to a UK NHS trust with community acquired bacteraemia. Hounsom L, Grayson K, Melzer M. Postgrad Med J; 2011 Nov; 87(1033):757-62. PubMed ID: 21798969 [Abstract] [Full Text] [Related]
2. Thirty-day mortality in UK patients with community-onset and hospital-acquired meticillin-susceptible Staphylococcus aureus bacteraemia. Melzer M, Welch C. J Hosp Infect; 2013 Jun; 84(2):143-50. PubMed ID: 23602415 [Abstract] [Full Text] [Related]
4. Risk factors and treatment outcomes of community-onset bacteraemia caused by extended-spectrum beta-lactamase-producing Escherichia coli. Kang CI, Song JH, Chung DR, Peck KR, Ko KS, Yeom JS, Ki HK, Son JS, Lee SS, Kim YS, Jung SI, Kim SW, Chang HH, Ryu SY, Kwon KT, Lee H, Moon C, Shin SY, Korean Network for Study of Infectious Diseases (KONSID). Int J Antimicrob Agents; 2010 Sep; 36(3):284-7. PubMed ID: 20580534 [Abstract] [Full Text] [Related]
11. Comparison of both clinical features and mortality risk associated with bacteremia due to community-acquired methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus. Wang JL, Chen SY, Wang JT, Wu GH, Chiang WC, Hsueh PR, Chen YC, Chang SC. Clin Infect Dis; 2008 Mar 15; 46(6):799-806. PubMed ID: 18266610 [Abstract] [Full Text] [Related]
13. Emergence of extended-spectrum β-lactamase-producing escherichia coli as a cause of community-onset bacteremia in South Korea: risk factors and clinical outcomes. Park SH, Choi SM, Lee DG, Kim J, Choi JH, Kim SH, Kwon JC, Yoo JH. Microb Drug Resist; 2011 Dec 15; 17(4):537-44. PubMed ID: 21875342 [Abstract] [Full Text] [Related]
14. Knowing prior methicillin-resistant Staphylococcus aureus (MRSA) infection or colonization status increases the empirical use of glycopeptides in MRSA bacteraemia and may decrease mortality. Robinson JO, Phillips M, Christiansen KJ, Pearson JC, Coombs GW, Murray RJ. Clin Microbiol Infect; 2014 Jun 15; 20(6):530-5. PubMed ID: 24224545 [Abstract] [Full Text] [Related]
15. Clinical significance of healthcare-associated infections in community-onset Escherichia coli bacteraemia. Cheong HS, Kang CI, Kwon KT, Heo ST, Wi YM, Kim ES, Lee JS, Ko KS, Chung DR, Lee NY, Song JH, Peck KR. J Antimicrob Chemother; 2007 Dec 15; 60(6):1355-60. PubMed ID: 17923453 [Abstract] [Full Text] [Related]
17. Determinants of Outcome in Hospitalized Patients With Methicillin-Resistant Staphylococcus aureus Bloodstream Infection: Results From National Surveillance in Canada, 2008-2012. Simor AE, Pelude L, Golding G, Fernandes R, Bryce E, Frenette C, Gravel D, Katz K, McGeer A, Mulvey MR, Smith S, Weiss K, Canadian Nosocomial Infection Surveillance Program. Infect Control Hosp Epidemiol; 2016 Apr 15; 37(4):390-7. PubMed ID: 26782274 [Abstract] [Full Text] [Related]
18. Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia. Bassetti M, Trecarichi EM, Mesini A, Spanu T, Giacobbe DR, Rossi M, Shenone E, Pascale GD, Molinari MP, Cauda R, Viscoli C, Tumbarello M. Clin Microbiol Infect; 2012 Sep 15; 18(9):862-9. PubMed ID: 21999245 [Abstract] [Full Text] [Related]
19. Community-onset healthcare-associated MRSA bacteraemia in a district general hospital. Karas JA, Enoch DA, Emery MM. J Hosp Infect; 2006 Apr 15; 62(4):480-6. PubMed ID: 16455162 [Abstract] [Full Text] [Related]
20. Australian Staphylococcus aureus Sepsis Outcome Programme annual report, 2013. Coombs GW, Nimmo GR, Daly DA, Le TT, Pearson JC, Tan HL, Robinson JO, Collignon PJ, McLaws ML, Turnidge JD, Australian Group on Antimicrobial Resistance. Commun Dis Intell Q Rep; 2014 Dec 31; 38(4):E309-19. PubMed ID: 25631593 [Abstract] [Full Text] [Related] Page: [Next] [New Search]